Knollwood Investment Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Hold
31,078
0.2% 103
2025
Q4
$2.06M Hold
31,078
0.19% 108
2025
Q3
$2.09M Sell
31,078
-122
-0.4% -$9.65K 0.19% 117
2025
Q2
$2.72M Hold
31,200
0.26% 93
2025
Q1
$2.13M Hold
31,200
0.24% 110
2024
Q4
$2.43M Hold
31,200
0.25% 98
2024
Q3
$2.09M Hold
31,200
0.22% 112
2024
Q2
$3.54M Buy
31,200
+28,180
+933% +$3.56M 0.39% 58
2024
Q1
$419K Hold
3,020
0.08% 156
2023
Q4
$375K Buy
+3,020
New +$309K 0.08% 158

Other funds holding DXCM

Knollwood Investment Advisory's DXCM Position: Q1 2026 in Review

Knollwood Investment Advisory held its DexCom (DXCM) position steady in Q1 2026 at 31,078 shares worth $1.95M. The position accounts for 0.2% of the portfolio, ranked #103.

Knollwood Investment Advisory first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.54M in Q2 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Knollwood Investment Advisory held 31,078 shares of DexCom worth $1.95M as of Q1 2026.
  • Knollwood Investment Advisory left its DexCom share count unchanged in Q1 2026.
  • DexCom made up 0.2% of Knollwood Investment Advisory's portfolio in Q1 2026, its #103 holding.
  • Knollwood Investment Advisory first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • Knollwood Investment Advisory's DexCom position peaked at $3.54M in Q2 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.